Concepedia

Joaquim Bellmunt

JB

Statistics

Publications

335

Citations

53.3K

H-Index

88

Active since

1989

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Memorial Sloan Kettering Cancer Center

Hospital Del Mar

Institut Gustave Roussy

Joaquim Bellmunt is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and chemotherapy.

Publications per year

1989–2025

335

Publications

335

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles et al. · The Lancet · 2016 · 3.7K citations

Medicine, Oncology, Pharmacotherapy +13

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine · 2017 · 3.4K citations · Full text

Medicine, Oncology, Pharmacology +17

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 3.3K citations · Full text

Medicine, Oncology, Urology +17

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson, Jaegil Kim, Hikmat Al‐Ahmadie et al. · Cell · 2017 · 2.5K citations · Full text

Medicine, Molecular Biology, Oncology +14

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles, Joseph P. Eder, Gregg Fine et al. · Nature · 2014 · 2.4K citations

Medicine, Oncology, Pharmacology +12

1–5 of 335